Lysophosphatidic acid is a bioactive mediator in ovarian cancer

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1582, Issue 1-3, 2002, Pages 257-264

  Fang, Xianjun ^a   Schummer, Michel ^b   Mao, Muling ^a   Yu, Shuangxing ^a   Tabassam, Fazal Haq ^a   Swaby, Ramona ^a   Hasegawa, Yutaka ^a   Tanyi, Janos L ^a   LaPushin, Ruthie ^a   Eder, Astrid ^a   Jaffe, Robert ^c   Erickson, Jim ^d   Mills, Gordon B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AGY Therapeutics Inc   (United States)

Author keywords

Cancer therapy; Cell survival; Edg receptor; Lysophosphatidic acid; Ovarian cancer

Indexed keywords

ANGIOGENIC FACTOR; G PROTEIN COUPLED RECEPTOR; G(Q) PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; LYSOPHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

CANCER GROWTH; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CELL SURVIVAL; CELL TYPE; GENE EXPRESSION; GENE INDUCTION; HUMAN; NONHUMAN; OVARY CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW;

FEMALE; HUMANS; LYSOPHOSPHOLIPIDS; OVARIAN NEOPLASMS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; REFERENCE VALUES;

EID: 0242339246     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00179-8     Document Type: Review

References (68)

1. Ovarian cancer: An update on genetics and therapy
2. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer
3. Lysophosphatidic acid, a multifunctional phospholipid messenger
4. The bioactive phospholipid lysophosphatidic acid is released from activated platelets
5. Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis
6. Lysophosphatidate-induced cell proliferation: Identification and dissection of signaling pathways mediated by G proteins
7. Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells
8. Lysophosphatidic acid: A novel growth survival factor for renal proximal tubular cells
9. Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway
10. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax
11. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid
12. Lysophosphatidic acid prevents apoptosis in fibroblasts via Gi-protein mediated activation of mitogen-activated protein kinase
13. Lysophosphatidic acids: II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets
14. Lysophosphatidic acid enhances contractility of isolated airway smooth muscle
15. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D
16. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
17. Regulatory mechanisms in ascitic fluid
18. A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization, and mechanism of action
19. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells
20. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients
21. Lysophosphatidic acid synthesis and release
22. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: Role of phospholipase D and phospholipase A2
23. The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D: Comparison with the response to endothelin
24. Growth factor-like action of phosphatidic acid
25. Human type 2 phosphatidic acid phosphohydrolases: Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform
26. Identification of a novel human phosphatidic acid phosphatase type 2 isoform
27. 2+ control lysophosphatidate signaling through EDG-2 receptors
28. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is edg-receptor independent
29. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells
30. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers
31. Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells
32. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: Comparison of the lysophospholipid contents in malignant vs. nonmalignant ascitic fluids
33. The LPA receptors
34. A subfamily of G protein-coupled cellular receptors for lysophospholipids and lysosphingolipids
35. Sphingosine 1-phosphate receptors
36. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes
37. Pharmacological characterization of phospholipid growth-factor receptors
38. Mammalian PSP24s (alpha and beta isoforms) are not responsive to lysophosphatidic acid in mammalian expression systems
39. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1
40. Lysophosphatidic acid stimulates tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130: Signaling pathways and cross-talk with platelet-derived growth factor
41. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner
42. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer
43. Lysophospholipids activate ovarian and breast cancer cells
44. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
45. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons
46. Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells
47. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
48. Fibronectin and its integrin receptors in cancer
49. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system
50. The heterotrimeric G protein G alpha i2 mediates lysophosphatidic acid-stimulated induction of the c-fos gene in mouse fibroblasts
51. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: A critical role for the mitogen-activated protein kinase p38 and for Rho proteins
52. Induction of connective tissue growth factor by activation of heptahelical receptors: Modulation by Rho proteins and the actin cytoskeleton
53. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells
54. Upregulation of endothelin-1 production by lysophosphatidic acid in rat aortic endothelial cells
55. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells
56. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells
57. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
58. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
59. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells
60. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: Over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer
61. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists
62. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior
63. Lysophospholipid receptors
64. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes
65. Analysis of the EDG2 receptor based on the structure/activity relationship of LPA
66. Determinants of receptor subtype specificity in the LPA-like lipid mediator family
67. Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
68. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid